CD86 is Expressed on Murine Hematopoietic Stem Cells and Denotes Lymphopoietic Potential

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2012 Feb 29

PMID 22371880

Citations 26

Authors

Tomoyuki Shimazu

Ryuji Iida

Qingzhao Zhang

Robert S Welner

Kay L Medina

Jose Alberola-lla

Paul W Kincade

Affiliations

Soon will be listed here.

Abstract

A unique subset of CD86(-) HSCs was previously discovered in mice that were old or chronically stimulated with lipopolysaccharide. Functionally defective HSCs were also present in those animals, and we now show that CD86(-) CD150(+) CD48(-) HSCs from normal adult mice are particularly poor at restoring the adaptive immune system. Levels of the marker are high on all progenitors with lymphopoietic potential, and progressive loss helps to establish relations between progenitors corresponding to myeloid and erythroid lineages. CD86 represents an important tool for subdividing HSCs in several circumstances, identifying those unlikely to generate a full spectrum of hematopoietic cells.

Citing Articles

Hematologic dysfunction in cancer: Mechanisms, effects on antitumor immunity, and roles in disease progression.

Plackoska V, Shaban D, Nijnik A Front Immunol. 2022; 13:1041010.

PMID: 36561751 PMC: 9763314. DOI: 10.3389/fimmu.2022.1041010.

Bone Marrow Immune Microenvironment in Myelodysplastic Syndromes.

Kouroukli O, Symeonidis A, Foukas P, Maragkou M, Kourea E Cancers (Basel). 2022; 14(22).

PMID: 36428749 PMC: 9688609. DOI: 10.3390/cancers14225656.

Hematopoietic and Chronic Myeloid Leukemia Stem Cells: Multi-Stability versus Lineage Restriction.

Brown G Int J Mol Sci. 2022; 23(21).

PMID: 36362357 PMC: 9655164. DOI: 10.3390/ijms232113570.

Lessons to cancer from studies of leukemia and hematopoiesis.

Brown G Front Cell Dev Biol. 2022; 10:993915.

PMID: 36204679 PMC: 9531023. DOI: 10.3389/fcell.2022.993915.

CD49b identifies functionally and epigenetically distinct subsets of lineage-biased hematopoietic stem cells.

Somuncular E, Hauenstein J, Khalkar P, Johansson A, Dumral O, Frengen N Stem Cell Reports. 2022; 17(7):1546-1560.

PMID: 35714596 PMC: 9287668. DOI: 10.1016/j.stemcr.2022.05.014.

References

Esplin B, Shimazu T, Welner R, Garrett K, Nie L, Zhang Q . Chronic exposure to a TLR ligand injures hematopoietic stem cells. J Immunol. 2011; 186(9):5367-75. PMC: 3086167. DOI: 10.4049/jimmunol.1003438. View

Karsunky H, Inlay M, Serwold T, Bhattacharya D, Weissman I . Flk2+ common lymphoid progenitors possess equivalent differentiation potential for the B and T lineages. Blood. 2008; 111(12):5562-70. PMC: 2424154. DOI: 10.1182/blood-2007-11-126219. View

Kiel M, Yilmaz O, Iwashita T, Yilmaz O, Terhorst C, Morrison S . SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell. 2005; 121(7):1109-21. DOI: 10.1016/j.cell.2005.05.026. View

Dykstra B, Kent D, Bowie M, McCaffrey L, Hamilton M, Lyons K . Long-term propagation of distinct hematopoietic differentiation programs in vivo. Cell Stem Cell. 2008; 1(2):218-29. DOI: 10.1016/j.stem.2007.05.015. View

Akashi K, Traver D, Miyamoto T, Weissman I . A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000; 404(6774):193-7. DOI: 10.1038/35004599. View

Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, Fehervari Z . CTLA-4 control over Foxp3+ regulatory T cell function. Science. 2008; 322(5899):271-5. DOI: 10.1126/science.1160062. View

Franco C, Scripture-Adams D, Proekt I, Taghon T, Weiss A, Yui M . Notch/Delta signaling constrains reengineering of pro-T cells by PU.1. Proc Natl Acad Sci U S A. 2006; 103(32):11993-8. PMC: 1567686. DOI: 10.1073/pnas.0601188103. View

Freeman G, Borriello F, Hodes R, Reiser H, Gribben J, Ng J . Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J Exp Med. 1993; 178(6):2185-92. PMC: 2191273. DOI: 10.1084/jem.178.6.2185. View

Lai A, Kondo M . Asymmetrical lymphoid and myeloid lineage commitment in multipotent hematopoietic progenitors. J Exp Med. 2006; 203(8):1867-73. PMC: 2118384. DOI: 10.1084/jem.20060697. View

10.

Ehninger A, Trumpp A . The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in. J Exp Med. 2011; 208(3):421-8. PMC: 3058583. DOI: 10.1084/jem.20110132. View

11.

Muller-Sieburg C, Cho R, Karlsson L, Huang J, Sieburg H . Myeloid-biased hematopoietic stem cells have extensive self-renewal capacity but generate diminished lymphoid progeny with impaired IL-7 responsiveness. Blood. 2004; 103(11):4111-8. DOI: 10.1182/blood-2003-10-3448. View

12.

Zheng X, Gao J, Chang X, Wang Y, Liu Y, Wen J . B7-CD28 interaction promotes proliferation and survival but suppresses differentiation of CD4-CD8- T cells in the thymus. J Immunol. 2004; 173(4):2253-61. DOI: 10.4049/jimmunol.173.4.2253. View

13.

Gray Parkin K, Stephan R, Lill-Elghanian D, Lee K, Saha B, Witte P . Expression of CD28 by bone marrow stromal cells and its involvement in B lymphopoiesis. J Immunol. 2002; 169(5):2292-302. DOI: 10.4049/jimmunol.169.5.2292. View

14.

Nutt S, Morrison A, Dorfler P, Rolink A, Busslinger M . Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments. EMBO J. 1998; 17(8):2319-33. PMC: 1170575. DOI: 10.1093/emboj/17.8.2319. View

15.

Beerman I, Bhattacharya D, Zandi S, Sigvardsson M, Weissman I, Bryder D . Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proc Natl Acad Sci U S A. 2010; 107(12):5465-70. PMC: 2851806. DOI: 10.1073/pnas.1000834107. View

16.

Hayakawa Y, Takeda K, Yagita H, Van Kaer L, Saiki I, Okumura K . Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. J Immunol. 2001; 166(10):6012-8. DOI: 10.4049/jimmunol.166.10.6012. View

17.

Martin C, Aifantis I, Scimone M, von Andrian U, Reizis B, von Boehmer H . Efficient thymic immigration of B220+ lymphoid-restricted bone marrow cells with T precursor potential. Nat Immunol. 2003; 4(9):866-73. DOI: 10.1038/ni965. View

18.

Nutt S, Metcalf D, DAmico A, Polli M, Wu L . Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors. J Exp Med. 2005; 201(2):221-31. PMC: 2212785. DOI: 10.1084/jem.20041535. View

19.

Sato T, Laver J, Ogawa M . Reversible expression of CD34 by murine hematopoietic stem cells. Blood. 1999; 94(8):2548-54. View

20.

Hu M, Bassett J, Danks L, Howell P, Xu K, Spanoudakis E . Activated invariant NKT cells regulate osteoclast development and function. J Immunol. 2011; 186(5):2910-7. DOI: 10.4049/jimmunol.1002353. View